ARCHIVES

FDA Relies on Importation, Fast Approval, and Early Reporting to Combat Drug Shortages

This article is from The Cancer Letter archive.

Vol. 38 No. 08 | February 24, 2012

Download PDF Visit The Full Archive

Related Articles

FDA Approves Aranesp For Chemo-Induced Anemia

August 30, 2002

Medicare to cut payments for cancer drugs by 2-8%. ASCO estimates total cut in reimbursement at $500 million.

July 30, 2004

Economic Analyses Of New Therapies Useful In Phase III Studies, Trialists Say

July 24, 2009

Proteomics Promises Ways To Track Response To Therapy

April 25, 2003

NCI Begins Large National Clinical Trial To Validate Biomarker For Lung Cancer

October 31, 2008

NSABP Breast Cancer Prevention Trial Reports Final Results On Tamoxifen

November 25, 2005